In trading today, Xortx Therapeutics Inc shares closed at $4.24 after opening the day at $4.16. It traded at a low of $4.10 to a high of $4.24.

Shares decreased -1.40 percent from the previous day's close of $4.30.

During the day across North America, the TSX Composite closed tsx_percentage_change% at 21708.44, the S&P 500 closed sp_500_percentage_change% at 5022.21, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37753.31 and the Nasdaq Composite closed nasdaq_percentage_change% at 15683.37.

Xortx Therapeutics Inc traded under XRTX on the Toronto Venture Exchange (TSX-V).

A total of 1,900 shares was traded during the last trading day, with total trades of 14, while having an average volume of 3,490 over 5 days.

The TSX-V overall saw 2,663 price advancers against 2,504 declines and 146 unchanged.

During the prior 52 weeks, XRTX.VN has traded as high as $10.62 (April 20,2023) and low as $2.65 (December 28,2023). Moreover, in the last 12 months, Xortx Therapeutics Inc's shares have shrunken -53.81%, while they have soared 46.21% since the start of 2024.

Following today's trading, Xortx Therapeutics Inc has a market capitalization of $12.46 million on a float of 2,899 shares outstanding. Its annual EPS is $-3.60.

Xortx Therapeutics Inc is a TSX Biotechnology company headquartered in Calgary, CAN.

Currently, Xortx Therapeutics Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..